Michela Aurilio

675 total citations
23 papers, 560 citations indexed

About

Michela Aurilio is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Michela Aurilio has authored 23 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Radiology, Nuclear Medicine and Imaging, 8 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Michela Aurilio's work include Radiopharmaceutical Chemistry and Applications (11 papers), Neuroendocrine Tumor Research Advances (6 papers) and Medical Imaging Techniques and Applications (5 papers). Michela Aurilio is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (11 papers), Neuroendocrine Tumor Research Advances (6 papers) and Medical Imaging Techniques and Applications (5 papers). Michela Aurilio collaborates with scholars based in Italy, Switzerland and Germany. Michela Aurilio's co-authors include Luigi Aloj, Diego Tesauro, Giancarlo Morelli, Antonella Accardo, Secondo Lastoria, Rosalba Mansi, Carla Cicala, Francesco Μaione, Giuseppe De Rosa and Giuseppina Salzano and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Medicinal Chemistry and International Journal of Cancer.

In The Last Decade

Michela Aurilio

21 papers receiving 555 citations

Peers

Countries citing papers authored by Michela Aurilio

Since Specialization

Citations

This map shows the geographic impact of Michela Aurilio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michela Aurilio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michela Aurilio more than expected).

Fields of papers citing papers by Michela Aurilio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michela Aurilio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michela Aurilio. The network helps show where Michela Aurilio may publish in the future.

Co-authorship network of co-authors of Michela Aurilio

This figure shows the co-authorship network connecting the top 25 collaborators of Michela Aurilio. A scholar is included among the top collaborators of Michela Aurilio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michela Aurilio. Michela Aurilio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	[225Ac]Ac-PSMA-617 production method: development of an efficient and reproducible radiolabelling process for establish a clinical routine production 2025 ·EJNMMI Radiopharmacy and Chemistry ·Michela Aurilio, (unknown), (unknown), (unknown), (unknown), Stefania Scala, Secondo Lastoria	0
2	Analysis of Pros and Cons in Using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007: Production, Costs, and PET/CT Applications in Patients with Prostate Cancer 2022 ·Molecules ·(unknown), Michela Aurilio, (unknown), (unknown), (unknown), Luciano Carideo, (unknown), Francesca Di Gennaro, (unknown), (unknown), (unknown), (unknown), (unknown), Alfredo Rossi, (unknown), Secondo Lastoria	18
3	On site production of [18F]PSMA-1007 using different [18F]fluoride activities: practical, technical and economical impact 2021 ·EJNMMI Radiopharmacy and Chemistry ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Michela Aurilio, (unknown), (unknown), (unknown), Secondo Lastoria	12
4	Novel Peptide-Based PET Probe for Non-invasive Imaging of C-X-C Chemokine Receptor Type 4 (CXCR4) in Tumors 2021 ·Journal of Medicinal Chemistry ·Anna Maria Trotta, Michela Aurilio, Crescenzo D’Alterio, Caterina Ieranò, (unknown), Antônio Barbieri, Antonio Luciano, (unknown), Sara Santagata, Luigi Portella, Stefano Tomassi, Luciana Marinelli, Deborah Sementa, Ettore Novellino, Secondo Lastoria, Stefania Scala, Margret Schottelius, Salvatore Di Maro	12
5	Structure–Activity Relationships and Biological Characterization of a Novel, Potent, and Serum Stable C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonist 2017 ·Journal of Medicinal Chemistry ·Salvatore Di Maro, Francesco Saverio Di Leva, Anna Maria Trotta, Diego Brancaccio, Luigi Portella, Michela Aurilio, Stefano Tomassi, Anna Messere, Deborah Sementa, Secondo Lastoria, Alfonso Carotenuto, Ettore Novellino, Stefania Scala, Luciana Marinelli	23
6	Pre-clinical evaluation of eight DOTA coupled gastrin-releasing peptide receptor (GRP-R) ligands for in vivo targeting of receptor-expressing tumors 2016 ·EJNMMI Research ·Antonella Accardo, Filippo Galli, Rosalba Mansi, Luigi Del Pozzo, Michela Aurilio, (unknown), (unknown), Alberto Signore, Giancarlo Morelli, Luigi Aloj	27
7	Role of 68Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1) 2015 ·Endocrine ·Secondo Lastoria, Francesca Marciello, Antongiulio Faggiano, Luigi Aloj, Corradina Caracò, Michela Aurilio, (unknown), Francesca Di Gennaro, Valeria Ramundo, Luigi Camera, Leonardo De Luca, Rosa Fonti, Vincenzo Napolitano, Annamaria Colao	42
8	Receptor binding peptides for target-selective delivery of nanoparticles encapsulated drugs 2014 ·International Journal of Nanomedicine ·Diego Tesauro, (unknown), Luigi Aloj, Giancarlo Morelli, Michela Aurilio	80
9	Radioimmunotherapy with Tenarad, a 131I-labelled antibody fragment targeting the extra-domain A1 of tenascin-C, in patients with refractory Hodgkin's lymphoma 2014 ·European Journal of Nuclear Medicine and Molecular Imaging ·Luigi Aloj, (unknown), Michela Aurilio, (unknown), Ferdinando Frigeri, Corradina Caracò, Francesca Di Gennaro, Gaetana Capobianco, Leonardo Giovannoni, Hans D. Menssen, Dario Neri, Antonio Pinto, Secondo Lastoria	25
10	Bombesin peptide antagonist for target-selective delivery of liposomal doxorubicin on cancer cells 2012 ·Journal of drug targeting ·Antonella Accardo, Rosalba Mansi, Giuseppina Salzano, (unknown), Michela Aurilio, Antonio Parisi, Francesco Μaione, Carla Cicala, (unknown), Diego Tesauro, Luigi Aloj, Giuseppe De Rosa, Giancarlo Morelli	35
11	Peptide-modified liposomes for selective targeting of bombesin receptors overexpressed by cancer cells: a potential theranostic agent 2012 ·International Journal of Nanomedicine ·Giancarlo Morelli, Antonella Accardo, Diego Tesauro, Carla Cicala, Giuseppina Salzano, Giuseppe De Rosa, (unknown), Luigi Aloj, Michela Aurilio, Francesco Μaione, Antonio Parisi	56
12	Gastrin and cholecystokinin peptide‐based radiopharmaceuticals: an in vivo and in vitro comparison 2011 ·Journal of Peptide Science ·Anna Lucia Tornesello, Michela Aurilio, Antonella Accardo, (unknown), Antônio Barbieri, Claudio Arra, Diego Tesauro, Giancarlo Morelli, Luigi Aloj	15
13	Comparison of the binding and internalization properties of 12 DOTA-coupled and 111In-labelled CCK2/gastrin receptor binding peptides: a collaborative project under COST Action BM0607 2011 ·European Journal of Nuclear Medicine and Molecular Imaging ·Luigi Aloj, Michela Aurilio, (unknown), (unknown), Diego Tesauro, Petra Kolenc Peitl, Θεοδοσία Μάινα, Rosalba Mansi, Elisabeth von Guggenberg, Lieke Joosten, Jane Sosabowski, Wouter A.P. Breeman, Erik de Blois, Stuart Koelewijn, Marleen Melis, Beatrice Waser, (unknown), Jean Claude Reubi, Marion de Jong	54
14	Peptide modified nanocarriers for selective targeting of bombesin receptors 2010 ·Molecular BioSystems ·Antonella Accardo, Rosalba Mansi, (unknown), Gaetano Mangiapia, Luigi Paduano, Diego Tesauro, Aurel Rădulescu, Michela Aurilio, Luigi Aloj, Claudio Arra, Giancarlo Morelli	40
15	Noninvasive Repetitive Imaging of Somatostatin Receptor 2 Gene Transfer with Positron Emission Tomography 2010 ·Human Gene Therapy ·Gabriella Cotugno, Michela Aurilio, Patrizia Annunziata, Anita Capalbo, Armida Faella, (unknown), Caterina Strisciuglio, (unknown), Luigi Aloj, Alberto Auricchio	21
16	Different Serum Enzyme Levels Are Required to Rescue the Various Systemic Features of the Mucopolysaccharidoses 2009 ·Human Gene Therapy ·Gabriella Cotugno, Alessandra Tessitore, Anita Capalbo, Patrizia Annunziata, Caterina Strisciuglio, Armida Faella, Michela Aurilio, (unknown), Fabio Russo, Antonio Mancini, Elvira De Leonibus, Luigi Aloj, Alberto Auricchio	21
17	Ga-68 DOTATE PET in endocrine tumors: Comparison with SRS, dosimetry, clinical impact 2009 ·Secondo Lastoria, (unknown), Michela Aurilio, Corradina Caracò, Luigi Aloj	1
18	Biophysical and biochemical characterization of a liposarcoma‐derived recombinant MnSOD protein acting as an anticancer agent 2008 ·International Journal of Cancer ·Aldo Mancini, Antonella Borrelli, (unknown), Luigi Aloj, Michela Aurilio, Francesco Morelli, Alessandra Pica, (unknown), (unknown), Roberto E. Mancini, (unknown), L. Mazzarella, Filomena Sica, Paolo Grieco, Ettore Novellino, Daniela Pagnozzi, Piero Pucci, Jean Rommelaere	21
19	The [Tc(N)(PNP)]²⁺ metal fragment labeled cholecystokinin‐8 (CCK8) peptide for CCK‐2 receptors imaging: in vitro and in vivo studies 2007 ·Journal of Peptide Science ·(unknown), Cristina Bolzati, (unknown), (unknown), Fiorenzo Refosco, Luigi Aloj, Claudio Arra, Michela Aurilio, Anna Lucia Tornesello, Diego Tesauro, Giancarlo Morelli	13
20	Experimental study for an intraoperative probe for 18F imaging with a silicon pixel detector 2007 ·Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment ·A. Lauria, Giovanni Mettivier, M.C. Montesi, Luigi Aloj, Secondo Lastoria, Michela Aurilio, Paolo Russo	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact